Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Its programs include Aleniglipron (GSBR-1290), ACCG-2671, GIP and GCG Receptor Oral Small Molecule Obesity Programs, ANPA-0073, and LTSE-2578. Its Aleniglipron is an oral and biased small molecule agonist of GLP-1R, a validated GPCR drug target for obesity. ACCG-2671 is an oral small molecule amylin receptor agonist for obesity. ANPA-0073 is a biased agonist targeting the apelin (APJ) receptor agonist. Its LTSE-2578, an Oral Small Molecule LPA1R Antagonist for IPF. It is developing an antagonist that targets lysophosphatidic acid 1 receptor (LPA1R), a GPCR implicated in responses to tissue injury and pro-fibrotic processes, for the treatment of IPF. It is developing oral incretins for potential combination therapy with GLP-1R or amylin candidates.
Find out what a historical investment in STRUCTURE THERAPEUTICS, INC. would be worth today using our GPCR stock calculator.
Buying GPCR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in STRUCTURE THERAPEUTICS, INC. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in GPCR
What is the ticker symbol of STRUCTURE THERAPEUTICS, INC.?
The ticker symbol for STRUCTURE THERAPEUTICS, INC. is GPCR.
How much is one share of GPCR?
One share of GPCR is valued at $17.12 as of 20 November 2026.
What is the market capitalisation of STRUCTURE THERAPEUTICS, INC. GPCR?
As of 20 November 2026 STRUCTURE THERAPEUTICS, INC. has a market cap of $1.24B.
What is the 52-week high for STRUCTURE THERAPEUTICS, INC. stock?
The STRUCTURE THERAPEUTICS, INC. 52-week high stock price is $94.90.
What is the 52-week low for STRUCTURE THERAPEUTICS, INC. stock?
The STRUCTURE THERAPEUTICS, INC. 52-week low stock price is $16.88.
Can I buy GPCR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy GPCR shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in GPCR on Stake
Buy GPCR from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of GPCR from only US$10 with fractional shares